Company Profile

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 65 active clinical sites in the United States, Canada, and Europe.

Latest News

View All News
View All News

Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023
Earnings Release
PDF HTML
Earnings Webcast
Audio
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

Report Links

Company Overview

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 65 active clinical sites in the United States, Canada, and Europe.

View Company Info

Leadership

View Management Team View Board of Directors

Investor Contact Information

Investor Relations

ClearPoint Neuro
Danilo D'Alessandro
ir@clearpointneuro.com

Transfer Agent

Continental Stock Transfer & Trust Company
One State Street Plaza
30th Floor
New York, NY 10004
T: 212-509-4000
F: 212-509-5150
https://continentalstock.com

Outside Legal Counsel

Bass, Berry & Sims PLC
100 Peabody Place
Suite 1300
Memphis, TN 38103
T: 901-543-5933
https://www.bassberry.com